BNET Industries

Novozymes A/S

NZYM is in the Manufacturing Industry

Market Cap:$14.6M
Last Fiscal Year Sales:$1.3B
  • Public
  • DK
Dow Jones Description

Mfr. & Supplier of Enzymes

President & CEO
Steen Riisgaard
Number of Employees 4,853
Contact Information

Krogshoejvej 36

Bagsvaerd DK 2880

www.novozymes.c...

(45) 8249999

NAICS Code All Other Basic Organic Chemical Manufacturing: 325199

News & Analysis

novozymes a/s - All News and Analysis

Decision Makers

Name (plus bio) Position
Steen Riisgaard President & CEO
Benny Loft CFO & Executive Vice President
Peder Holk Nielsen Executive Vice President & Head, Enzymes Business
Thomas Nagy Executive Vice President, Stakeholder Relations
Thomas Videbaek Executive Vice President, Bio Business
Kurt Anker Nielson Senior Vice President
Paul Petter Aas Senior Vice President
Anna Lise Vice President of Stakeholder Communications
Mette Vestergaard Vice President, HR
Anders Boegh Jensen Project Manager
Niels Kildegaard Pedersen Global Business Manager
Caspar Foghsgaard
Charlotte Hummer Vad
Hans Ole Klingenberg
J O rgen Thorball
Peder Holk
Svend Erik Licht
Kurt Anker Nielsen Director

Board of Directors

Name (plus bio) Position
Henrick Guertler Chair of Board
Dr Mathias UhlEn Board of Directors
Henrik Gurtler Board of Directors
Jerker Hartwall Board of Directors
Jerker Hartwell Board of Directors
Lars Bo Koppler Board of Directors
Michael Munkso Board of Directors
Paul Petter Aas Board of Directors
Soren Henrik Board of Directors
SOren Henrik Jepsen Board of Directors
Ulla Morin Board of Directors
Walter Thygesen Board of Directors
Walther Thygesen Board of Directors

Organization Position Status
Novozymes A/S President & CEO Current

Organization Position Status
Novozymes A/S CFO & Executive Vice President Current

Organization Position Status
Novozymes A/S Executive Vice President & Head, Enzymes Business Current

Organization Position Status
Novozymes A/S Executive Vice President, Stakeholder Relations Current

Organization Position Status
Novozymes A/S Executive Vice President, Bio Business Current

Organization Position Status
Novozymes A/S Senior Vice President Current
Novozymes A/S Deputy Vice Chairman Current
Novozymes A/S Board of Directors Former

Organization Position Status
Novozymes A/S Senior Vice President Current
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Vice President of Stakeholder Communications Current
University of Copenhagen MSc in biology Former

Organization Position Status
Novozymes A/S Vice President, HR Current

Organization Position Status
Bridge Bioresearch Ltd Chief Scientific Officer Current
Novozymes A/S Project Manager Current

Niels Kildegaard Pedersen is the new global business manager for leather enzymes at Novozymes A/S. He will be focusing on introducing lipases and new fungal bating enzymes to the leather industry. In his previous 28 years with Novozymes, he was involved in sales and marketing introducing new enzymes to many of the industries served by Novozymes A/S.

Organization Position Status
Novozymes A/S Global Business Manager Current

Organization Position Status
Novozymes A/S Current

Organization Position Status
Novozymes A/S Current

Organization Position Status
Novozymes A/S Current

Organization Position Status
Novozymes A/S Current

Organization Position Status
Novozymes A/S Current
Technical University of Denmark MSc (chemical engineering) Former
Copenhagen Business School BCom (International Business Management) Former

Organization Position Status
Novozymes A/S Current

Organization Position Status
Novozymes A/S Chair of Board Current

Mathias Uhlen is Professor of Microbiology and Vice President at the Royal Institute of Technology (KTH), Stockholm, Sweden. Prof Uhlen is chairman for the Biotechnology Section at the Royal Swedish Academy of Engineering Science (IVA) and he is also a member of the Royal Swedish Academy of Science.

Organization Position Status
Royal Institute Vice President Current
Swetree Technologies Professor of Microbiology and Vice President at the Royal Institute of Technology (Kth) Current
Royal Institute of Technology Vice President Current
Affibody Ab Och Inforsense, Ltd. Co-Founder Current
Royal Institute of Technology Co-Founder Current
Royal Institute of Technology Professor Current
Affibody Ab Och Inforsense, Ltd. Board of Directors Current
Genpoint As Board Member Current
Swetree Technologies Board of Directors Current
Current Biodata Limited Board of Directors Current
Novozymes A/S Board of Directors Current
Royal Institute of Technology Ab, and Professor of Biotechnology Former

Organization Position Status
Novozymes A/S Board of Directors Current
Novozymes A/S Chairman of The Boards Former
Corporate Management Corp Board of Directors Former

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
TDC A/S Director Current
ZymoGenetics, Inc. Board of Directors Current
Norsk Hydro ASA Director Current
Novozymes A/S Director Current
Coloplast A/S Board of Directors Current
Booz Allen Hamilton, Inc. Management Consultant Former
Carlsberg A/S Business Economist Former
ZymoGenetics, Inc. Chairman Former
Novozymes A/S Vice Chairman Former
Copenhagen Business School M.A. In Commerce Former
Copenhagen Business School B.A. In Economics Former
Norsk Hydro ASA member Former

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Board of Directors Current
Novozymes A/S Senior Vice President Former

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Board of Directors Current

Organization Position Status
Novozymes A/S Board of Directors Current
advertisement
NZYM $1.00 +0.07 (7.53% )
Volume 19,060
Shares Outstanding 14.6M
Market Cap 14.6M
Year High 1.29
Year Low 0.40
Earnings Per Share 0.070
P/E Ratio 14.2857
Dividend 0.00
Yield 0.00
IndustryTop Rated
advertisement